NAMs Menopause Certification Exam Questions and Answers Latest Update 2024/2025 | VERIFIED.

NAMs Menopause Certification Exam Questions and
Answers Latest Update 2024/2025 | VERIFIED.




1. Climacteric phase answer>>>> The period of endrocrinologic, somatic, and transitory
nn n n n nn nn nn nn nn nn



psychologic changes that
nn nn nn




occur around the time of menopause.
nn nn nn nn nn




2. Early menopause answer>>>>
nn n n a n LMP before age 45
nn nn nn




3. Late menopause
n n answer>>>> LMP after age 54 n nn nn nn




4. Primary ovarian nn
nn (LOOP)
insufficiency
nn




5. Early menopause
nn




transition (stage
nn nn
8. Obese women and estradiol levels during
nn nn nn nn nn




-2) answer>>>> menopause
n n n




6. Late menopause
nn
9. answer>>>> Chinese and Japanese women n nn nn nn




transition (stage
nn nn




-1)

7. Luteal out of nn nn




phase
nn




event
nn




nn

,Menopause that occurs before age
nn nn nn nn



40
nn
Explains why some perimenopausal women have elevated estrogen level some-
nn nn nn nn nn nn nn nn nn




times...In the early menopause transition, elevated FSH levels are adequate to
nn nn nn nn nn nn nn nn nn nn nn




recruit a second follicle which results in a follicular phase-like rise in
n n nn nn nn nn nn nn nn nn nn nn nn




Persistent ditterence of 7 days or
nn nn nn nn nn estradiol secretion superimposed on the mid-to-latelutealphase ofthe ongoing
nn nn n n n n n n n n n



more in the length of consecutive
nn nn nn nn nn nn
ovulatory cycle.
n nn



cycles.
nn




Obese women are more likely to have anovulatory cycles with high estradiol
nn nn nn nn nn nn nn nn nn nn nn




levels. They are also more likely to have lower premenopause yet higher post-
nn nn nn nn nn nn nn nn nn nn nn nn nn




menopause estradiol levels compared with women of normal weight. (why
nn nn nn nn nn nn nn nn nn nn



60 or more consecutive days of
nn nn nn nn nn
they are at higher risk of endometrial cancer)
nn nn nn nn nn nn nn nn


amenorrhea
nn




These ethnic groups have lower estradiol levels then white, black and hispanic
nn nn nn nn nn nn nn nn nn nn nn




women.
nn




10. stage +2 n n late menopause stage: 5-8 years after FMP. Somatic aging predominates. In-
nn nn nn nn nn nn nn nn nn nn




creased genitourinary symptoms.
nn nn




nn

,11. Stages +1a, +1b, nn nn early post menopause: 2 years after FMP. FSH rises, estradiol decreases.
nn nn nn nn nn nn nn nn nn nn




+1c VMS predominate.
nn nn




12. Elevated FSH, LH Endocrine labs after menopause
nn nn nn nn nn




13. AMH, inhibin B n n n n These hormones work during reproductive years to not deplete follicle pool too
nn nn nn nn nn nn nn nn nn nn nn




quickly.

14. Phases during Menstrual cycle shortenes, follicular phase compresses, women spend more
nn nn nn nn nn nn nn nn nn




menopause tran- time in luteal phase.. meaning more premenstrual symptoms and more frequent
nn nn nn nn nn nn nn nn nn nn nn nn nn




sition and PMS menstrual periods.
nn nn nn nn nn




symptoms
nn




15. How to respond many pitfalls, variable depending on the day of the cycle you draw the lab, normal
n n n n nn nn nn nn nn nn nn nn nn nn nn nn nn nn



if
n n




a patient requests or low FSH is not helpful.
nn nn nn nn nn nn nn nn




FSH lab? nn




16. The potentially nn AMH
superior marker
nn nn




of menopause,
nn nn




a lab.
nn nn




17. DHEA Adrenal androgens: precursor hromones produced by the adrenal gland that are
nn nn nn nn nn nn nn nn nn nn




(dehy- enzymatically converted to active androgens or estrogens in peripheral tissues.
nn nn nn nn nn nn nn nn nn nn




droepiandros
nn




- terone)
nn




18. Location of estro- Vagina, vulva, urethra, trigone of the bladder
nn nn nn nn nn nn nn nn




gen receptors
nn nn




19. Effects of estro- nn nn maintain blood flow, the collagen, and HA within the epithelial surfaces. Supports
nn nn nn nn nn nn nn nn nn nn nn




gen on tissue
nn nn nn microbiome and protects tissue from pathogens.
nn nn nn nn nn nn




nn

, 20. Vaginal changes nn
Is it a screening tool for fertility?
nn nn nn nn nn nn




with
nn




menopause
nn




21. Vagina and nn




urethra in
nn nn




menopaus
nn




e

22. Stress urinary in- nn nn




continence
nn




23. Treatment for nn




FPHL
nn




24. Late reporoduc-
nn




tive years -3b
nn nn nn




and
nn




-3a. What hap-
nn nn




pens with men-
nn nn nn




strual cycles, FSH,
nn nn nn




AMH, AFC,
nn nn




inhib- in?
nn nn




25. When it is nn nn




appro- priate to
nn nn nn




check an FSH
nn nn nn




during the cy- cle
nn nn nn nn




if you check it?
nn nn nn nn




and why?
nn nn




26. AMH
produced by... nn




used to test...
nn nn nn


nn